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Abstract
Calcium is one of the most abundant minerals in the body and its metabolism is one of the basic biologic
processes in humans. Although historically linked primarily to bone structural development and maintenance,
calcium is now recognized as a key component of many physiologic pathways necessary for optimum health
including cardiovascular, neurological, endocrine, renal, and gastrointestinal systems. A recent meta-analysis
published in August 2011 showed a potential increase in cardiovascular events related to calcium supplementation.
The possible mechanism of action of this correlation has not been well elucidated. This topic has generated
intense interest due to the widespread use of calcium supplements, particularly among the middle aged and
elderly who are at the most risk from cardiac events. Prior studies did not control for potential confounding factors
such as the use of statins, aspirin or other medications. These controversial results warrant additional well-designed
studies to investigate the relationship between calcium supplementation and cardiovascular outcomes. The
purpose of this review is to highlight the current literature in regards to calcium supplementation and
cardiovascular health; and to identify areas of future research.
Introduction
Calcium is one of the most abundant minerals in the
body and its metabolism is one of the basic biologic
processes in humans. Although historically linked pri-
marily to bone structural development and maintenance,
it is now recognized as a key aspect of many physiologic
pathways necessary for optimum health including the
cardiovascular, neurological, hormonal, renal, and gas-
trointestinal systems. Calcium serves as a cofactor for
many extracellular enzymes, most notably the enzymes
of the coagulation cascade, and as a source of calcium
ions that function as signaling molecules for a great
diversity of intracellular processes. These processes
include automaticity of nerve and muscle; contraction of
cardiac, skeletal, and smooth muscle; neurotransmitter
release; and various forms of endocrine and exocrine
secretion. Our review will describe the biology and basic
physiology of calcium metabolism in humans, the pre-
sent status of recommendations for intake and supple-
mentation, the traditional role of calcium for optimum
maintenance of the skeletal system, and then discuss in
detail the relevance of calcium in cardiovascular health
as well as several cardiac and vascular disease states.
Current status of knowledge
The body of the average adult contains about 1000 gram
of calcium of which 99% is located in the mineral phase
of bone as hydroxyapatite crystals [Ca10 (PO4)6(OH)2].
T h e s ec r y s t a l sp l a yak e yr o l ei nt h em e c h a n i c a lw e i g h t -
bearing properties of bone, serves as a source of calcium
to support a number of calcium-dependent biological
systems and to maintain blood ionized calcium within
normal range. The remaining 1% of total body calcium is
located in the blood, extracellular fluid and soft tissues.
Of the total calcium in blood, the ionized fraction (45%)
is the biologically functional portion and can be mea-
sured clinically. Most clinical laboratories report total
serum concentrations. Forty-five percent of the total cal-
cium in blood is bound to plasma, proteins notably albu-
min and up to 10% is bound to anions such as phosphate
and citrate. Concentrations of total calcium in normal
serum generally range between 8.5 and 10.5 mg/dl (2.12-
2.62 mM).
Mineral homeostasis
T h es k e l e t o n ,g u ta n dt h ek i d n e yp l a yam a j o rr o l ei n
assuring calcium homeostasis. Overall in a typical indivi-
dual, if 1000 mg of calcium is ingested per day, about
200 mg will be absorbed [1]. Approximately 10 gram of
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any medium, provided the original work is properly cited.calcium will be filtered daily through the kidney and most
will be reabsorbed, with about 200 mg being excreted in
the urine [1]. The skeleton, a storage site of approximately
1 kg of calcium, is the major calcium reservoir in the
body. Ordinarily as a result of normal bone turnover,
approximately 500 mg of calcium is released from bone
per day, and the equivalent amount is deposited per day
[1]. Parathyroid hormone (PTH) enhances bone resorption
and liberates both calcium and phosphate from the skele-
ton. PTH also enhances calcium re-absorption in the kid-
ney while at the same time inhibiting phosphate re-
absorption producing phosphaturia. Hypocalcemia and
PTH itself can both stimulate the conversion of the inert
metabolite of Vitamin D, 25-OH Vitamin D3 to the active
moiety 1, 25-dihydroxy Vitamin D3 which in turn
enhances intestinal calcium absorption (see Figure 1).
Background
Dietary calcium
Adequate calcium and Vitamin D intake along with regular
exercise is an important aspect of bone health. The body
cannot produce calcium, which must be ingested orally
either through foods naturally rich in calcium, calcium for-
tified foods, or calcium supplements. Dairy products are
naturally high in calcium. Milk, yogurt, and cheese are rich
natural sources of calcium and are the major food sources
of calcium in the United States [2]. Calcium-fortified foods
and calcium supplements are helpful for people who are
unable to get enough calcium in their regular diets.
IOM recommendations on calcium intake
Intake recommendations for calcium and other nutrients
are provided in the Dietary Reference Intakes (DRIs)
developed by the Food and Nutrition Board (FNB) at
Figure 1 Parathyroid hormone (PTH)-calcium feedback loop that controls calcium homeostasis. Four organs-the parathyroid glands,
intestine, kidney, and bone-together determine the parameters of calcium homeostasis. +, positive effect; -, negative effect; 1,25 D, 1,25-
dihydroxyvitamin D3; ECF, extracellular fluid.
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table 1) [2].
Calcium intake and status
The Institute of Medicine defines the Adequate Intake
(AI) of calcium as 1,000 mg/day for individuals aged 19 to
50 years and 1,200 mg/day for persons older than age 51
years, with the tolerable upper intake level (UL) of 2,500
mg/day. However, results from the National Health and
Nutrition Examination Survey (NHANES) found that only
15% of men and eight percent of women older than 71
years had dietary calcium intakes meeting AI levels [3].
Mean calcium intake levels for males ranged from 871 to
1,266 mg/day depending on life stage group; for females
the range was 748 to 968 mg/day [3]. Overall, females are
less likely than males to get recommended intakes of cal-
cium from food. About 43% of the U.S. population (almost
70% of older women) uses dietary supplements containing
calcium [3]. Overall 60 percent of women over 60 report
taking a dietary supplement containing calcium. About
30% of the calcium available in foods gets absorbed.
Absorption varies depending upon the type of food
consumed [2]. The efficiency of absorption decreases as
calcium intake increases [2]. Absorption decreases to 15%-
20% in adulthood (though it is increased during preg-
nancy) and continues to decrease as people age; therefore,
recommended calcium intakes are higher for females
older than 50 years and for both males and females older
than 70 years [2,4,5]. When calcium intake is low or
ingested calcium is poorly absorbed, bone breakdown
occurs as the body uses its stored calcium to maintain
normal biological functions
Calcium supplements
Surveys have shown that many Americans are taking
calcium supplements. The two main forms of calcium in
these supplements are carbonate and citrate. Calcium
supplements contain varying amounts of elemental cal-
cium. For example, calcium carbonate is 40% calcium by
weight, whereas calcium citrate is 21% calcium.
The amount of calcium absorbed from supplements
depend on the total amount of elemental calcium con-
sumed at one time; as the amount increases, the percen-
tage absorption decreases. Absorption is highest in doses
≤500 mg of elemental calcium at one time [2]. Supple-
menting calcium in a divided dose regimen can, for the
same ingested total load as in a single dose regimen, deli-
ver as much as 80%-100% more calcium into the body
[6]. Absorption of calcium from carbonate requires an
acidic environment and so calcium carbonate should be
taken with meals. Individuals taking medications that
decrease stomach acid like proton pump inhibitors or
H2-blockers should use calcium citrate supplements. Cal-
cium citrate should be used in individuals with suspected
achlorhydria, inflammatory bowel disease, or absorption
disorders; however calcium carbonate is absorbed nor-
mally if taken with food, even in the presence of these
conditions [7].
Calcium and health
Calcium and bone health
Bone mass increases during periods of growth in child-
hood and adolescence, reaching a peak around age 30
years. Adequate intake of calcium and Vitamin D is essen-
tial throughout childhood, adolescence and early adult-
hood. In pre-pubertal children whose average dietary
intake of calcium approximated the recommended dietary
allowance, calcium supplementation increased the rate of
increase in bone mineral density [8]. If the gain persists,
peak bone density should be increased thereby reducing
risk of fracture.
Bone undergoes continuous remodeling, with constant
resorption and deposition of calcium into new bone. In
aging adults, particularly among postmenopausal women,
bone breakdown exceeds formation, resulting in bone
loss that increases the risk of osteoporosis over time [2].
Calcium supplements mitigate the aging-related bone
loss. They also preserve bone in premenopausal women.
A controlled 2 year longitudinal trial of 248 perimeno-
pausal women observed that a daily supplementation
with 1000 or 2000 mg of calcium significantly reduced
bone turnover and bone loss from the lumbar spine in
premenopausal and early menopausal women for the two
years of study and an additional year of follow up [9].
The responsiveness of postmenopausal women to supple-
mentation with calcium appears to depend on their
menopausal age. In women who are within the first
5 years of menopause, bone loss is attenuated but not
arrested by added calcium. The maximal effect appears to
occur with supplement dosages of approximately 1000 mg
elemental calcium per day [9].
Calcium supplementation and cardiac health
Calcium supplements are widely used in the United States
and other developed nations, traditionally to avoid osteo-
penia and its complications, but now often given along
with vitamin D supplementation for maintenance of opti-
mum health for other physiologic processes, including the
cardiovascular system Many prior studies have shown
varying results in regards to calcium supplementation and
cardiovascular disease risk and outcomes.
Randomized placebo controlled trials As e c o n d a r y
analysis of a randomized placebo controlled trial of cal-
cium supplements versus placebo in post-menopausal
women for 5 years showed a statistically significant
increase in MI [10]. The composite end point of myocar-
dial infarction (MI), stroke or cerebrovascular accident
(CVA), or sudden death was higher in the calcium supple-
mented group (P = 0.008), relative risk was 1.66 [10].
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Life Stage Group Estimated Average Requirements (mg/day) Recommended Dietary Allowance (mg/day) Upper Level Intake (mg/day)
Infants 0-6 months 200 200 1000
Infants 6-12months 260 260 1500
1-3 years 500 700 2500
4-8 years 800 1000 3000
9-13 years 1100 1300 4000
14-18 years 1100 1300 4000
19-30 years 800 1000 4000
31-50 years 800 1000 4000
51-70 years 800 1000 4000
51-70 year old female 1000 1200 4000
71+ year old 1000 1200 4000
14-18 year old pregnant/lactating 1100 1300 4000
19-50 year old pregnant//lactating 800 1000 4000
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7When the events were adjudicated, statistical significance
was no longer found. The baseline characteristics of the
participants in this study were not adjusted for cardiovas-
cular risk nor was there adequate documentation for con-
comitant cardiovascular medications.
The Women’s Health Initiative trial, another rando-
mized controlled study did not show any significant cardi-
ovascular risk from calcium supplements. This was a RCT
of calcium 500 mg plus Vitamin D 200 IU twice daily ver-
sus placebo in 36,282 post-menopausal women 50 to 79
years at 40 clinical sites, where CVD was a pre-specified
secondary efficacy outcome. This study revealed that cal-
cium/vitamin D supplementation neither increased nor
decreased the risk for CHD or stroke in generally healthy
postmenopausal women throughout the 7-year duration
of this randomized trial [11]. Alimitation of this trial was
poor adherence to the supplements. At the end of the trial
(mean follow-up, 7 years), 76% of participants were taking
“some” study pills, and 59% were taking-80% of their study
medication. This may have played a role in neutral effects
on the cardiovascular risk. Another limitation of the trial
was that women in the placebo group were allowed to
continue their own calcium supplements. About 54% of
participants were taking personal calcium supplements at
randomization, which could have masked the difference
between the 2 groups on the effect of calcium and vitamin
D on the risk of cardiovascular events. In addition a high
percentage of women were using hormone replacement
therapy, which may have an independent role in cardiovas-
cular mortality.
A 5-year randomized, controlled trial (RCT) and 4.5
years of post-trial follow-up showed that 1200 mg of cal-
cium (as calcium carbonate) daily does not significantly
increase the risk of atherosclerotic vascular disease in
elderly women [12]. Further analysis of this RCT sug-
gested that calcium supplementation may reduce the risk
of hospitalization and mortality in patients with preexist-
ing atherosclerotic cardiovascular disease [12]. In addition,
the incidence of the heart failure outcome was reduced in
calcium-treated patients at 9.5 years [12]. The strengths of
this study over previous studies include the complete fol-
low-up of all 1460 participants and that the adverse events
were analyzed to provide clear end points [12].
Meta-analysis
A meta-analysis of 11 studies which included 12000 parti-
cipants showed that allocation to calcium supplements (>
500 mg/day for more than a year) was associated with
increased risk of MI and that calcium supplementation
was associated with 30% increase in incidence of MI, and
smaller non-significant increase in risk of CVA and death
[13]. None of the trials had CV events as the primary end
points and data on CV events were not gathered in a stan-
dardized manner. Incomplete or no data on CV outcomes
were available in 7 trials comprising about 15% of partici-
pants. None of the trials were designed to have the base-
line characteristics of the subjects equalized in terms of
cardiac risk factors. The trials did not have information
about the use of statins, ACE inhibitor therapy or previous
history of coronary artery disease. The studies which com-
pared calcium plus Vitamin D with placebo were excluded,
so the results may not apply to co-administered calcium
and Vitamin D supplements. Many commonly used cal-
cium supplements consumed or available currently in the
United States have Vitamin D included.
Prospective cohort study
A prospective cohort study of 34,486 postmenopausal
Iowa women 55-69 years old, without a history of ischemic
heart disease was analyzed to investigate whether greater
intakes of calcium, vitamin D, or milk products may pro-
tect against ischemic heart disease mortality. Eight year
follow up suggested that, among postmenopausal women,
the risk of dying of ischemic heart disease may be reduced
by consuming relatively high levels of calcium [14]. There
was an estimated statistically significant 33 percent reduc-
tion in risk for persons in the highest quartile of total cal-
cium intake (i.e., high whether due to diet, supplements,
or both). Limitation of the study was that the duration of
supplemental vitamin and mineral use was not known.
Observational cohort study
An observational cohort study of 9910 women aged 60-89
years with no pre-existing heart disease or stroke history
showed that after 2 years of calcium and vitamin D sup-
plementation there was no increase in cardiovascular
events or deaths compared to women who received mini-
mal supplementation [15]. How do calcium supplements
increase the risk of vascular events.
The mechanisms by which calcium supplements might
increase the risk of myocardial infarction are unclear and
speculative. A possible explanation is that calcium supple-
ments acutely increase serum calcium levels to a modest
degree stimulating the calcium sensing receptors on the
cells of the vessel wall and have deleterious effects [16]. It
is speculated that it may also increase vascular calcification
and thereby cardiovascular events [13]. Other possible
mechanisms may be increased coagulability, as the time to
initiation of coagulation is inversely related to ionized cal-
cium concentration [16]. Increased arterial stiffness may
play a role in vascular events [16].
Calcium supplementation and arterial calcification
The effect of calcium supplementation on arterial calcifi-
cation is unclear. Post-trial coronary artery calcification
(CAC) measurements using cardiac CT were similar in
women randomized to calcium/vitamin D supplementa-
tion (calcium/D) and those receiving placebo. Treatment
with moderate doses of calcium plus vitamin D3 did not
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among postmenopausal women [17].
In subjects new to hemodialysis, baseline CAC (coronary
artery calcification) score is a significant predictor of all-
cause mortality. Use of calcium-containing phosphate bin-
ders in patients new to hemodialysis is associated with a
rapidly progressive increase in the extent of CAC with
resultant higher mortality [18]. Total body calcium score
and progression of CAC score in predialysis patients was
shown to be higher with the use of calcium containing
phosphate binders versus non calcium containing phos-
phate binders [19]. Calcium supplementation can hypothe-
tically increase arterial calcification and cardiovascular
events, so calcium supplements should be used with cau-
tion in patients with renal disease. People with impaired
renal function who take calcium supplements may be at
higher risk of cardiovascular problems [20].
Calcium supplementation and blood pressure
Relationship between calcium intake/supplementation
and blood pressure or risk of hypertension is unclear.
The Women’s Health Initiative study revealed that over a
median follow-up time of 7 years, there was no signifi-
cant difference in the mean change over time in systolic
blood pressure (0.22 mm Hg, 95% CI -0.05 - 0.49 mm
Hg) and diastolic blood pressure (0.11 mm Hg, 95% CI
-0.04 - 0.27 mm Hg) between the active and placebo
treatment groups [11]. In postmenopausal women, cal-
cium plus vitamin D3 supplementation did not reduce
either blood pressure or the risk of developing hyperten-
sion over seven years of follow up.
A prospective cohort study of 28,886 US women aged
45 years, revealed that intakes of low-fat dairy products,
calcium, and vitamin D were each inversely associated
with risk of hypertension in middle-aged and older
women, suggesting their potential roles in the primary
prevention of hypertension and cardiovascular complica-
t i o n sd u r i n g1 0y e a r so ff o l l o w - u p[ 2 1 ] .T h i ss t u d yw a s
limited to white women.
Calcium and lipids
Limited data is available in regards to calcium intake/sup-
plementation on lipid profile. RCT of supplementation of
calcium citrate in normal older women showed beneficial
changes in circulating lipids in post-menopausal women.
After 12 months, HDL cholesterol levels and the HDL
cholesterol to LDL cholesterol ratio had increased more in
the calcium group than in the placebo group [21]. This
was largely due to a 7% increase in HDL cholesterol levels
in the calcium group, with a non-significant 6% decline in
LDL cholesterol levels. There was no significant treatment
effect on triglyceride level [22]. Calcium possibly binds to
fatty acids and bile acids in gut resulting in poor fat
absorption. Other possible mechanism include increased
lipolysis as a result of inhibition of PTH and 1, 25 (OH)2
Vitamin D.
Calcium and Diabetes
The available evidence on the role of calcium supplemen-
tation in the development of diabetes is limited, but a sys-
tematic review and meta-analysis suggests that combined
vitamin D and calcium supplementation may have a role
in the prevention of T2DM only in populations with
glucose intolerance, who are at high risk of developing
diabetes [23].
Conclusion
Osteoporosis is a growing health problem and a common
cause of morbidity. Adequate calcium intake is essential
for maintaining good bone health. As discussed above,
calcium supplements are commonly used in US to satisfy
the daily dietary recommendations of calcium. Calcium
supplements modestly increase bone density and have
marginal efficacy against fracture. The number of
patients needed to treat with calcium and or Vitamin D
supplementation for 5 years to prevent one fracture is
estimated to be 48 [24].
Cardiovascular disease is the main cause of mortality
and morbidity in US. Recently concern has been raised
regarding an increased risk of MI associated with calcium
supplements [10], raising questions about the safety of cal-
cium supplements with respect to cardiovascular disease
risk. Based on reported data, if 1000 people were given cal-
cium supplements for 5 years, theoretically there would be
an additional 14 myocardial infarction [10]. In the Iowa
Women’s Health Study, higher calcium intake was asso-
ciated with reduced ischemic heart disease mortality in
postmenopausal women [14]. Another RCT revealed that
calcium supplementation does not significantly increase
the risk of cardiovascular events [12].
These varying results should prompt more well designed
studies to investigate the relationship between calcium
supplements and cardiovascular health. Very few studies
in the past have been controlled for factors such as the use
of statins, aspirin, ACE inhibitors, ARBs or other medica-
tions and further research is needed in these matters In
addition some of the major studies have not adjudicated
CV events as a major outcome leading to potential data
collection bias. Adequate calcium intake/supplementation
is essential in childhood, adolescence and adulthood for
optimal bone health. Increased cardiovascular risk asso-
ciated with calcium supplementation in young women
would translate to a large burden of disease. This is specu-
lation and warrants further research. Osteoporosis is
becoming an increasing public problem in males as well.
Paucity of data exists on relationship of calcium supple-
mentation and cardiovascular risk in males. Further
research is needed to clarify the magnitude of this problem
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ism of adverse effects of calcium supplementation on car-
diovascular disease in males and females.
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